paediatric autoimmune encephalitis: clinical features autoimmune encephalitis... · ·...
TRANSCRIPT
Autoimmune encephalitis: theoretical and clinical perspectives
Ming Lim
Evelina Children’s Hospital
Clinical Neurology Laboratory, Oxford University
Overview of immune system
INNATE IMMUNITY
• First line of defence
• Rapid action
• Not specific
• Limited diversity / flexibility
• No memory
• Phagocytes, DCs, NKs, mast cells, eosinophils, basophils
• Complement, cytokines, defensins
ADAPTIVE IMMUNITY
• Role in eliminating infection
• Time lag (days)
• Antigen specific
• Diverse and flexible
• Memory response
• Lymphocytes
• Antibodies, cytokines
Inflammation in the brain
The molecular effectors Compromise of the blood brain barrier
Lim 2011 DMCN 53: 298-304
Astrocytes Microglia
Upregulation of the adaptive immune system
Inflammation in the brain
Cell type Condition
Th1 MS, ADEM, Rassmussen
encephalitis
Th2 SLE
B cell MS, NMO, demyelination, autoimmune encephalitis
Innate
HLH, SLE, Behcet, Sarcoid
Anti neural-antibodies and CNS autoimmunity
Antibodies against neuronal surface antigens
• VGKC (LGI1, CASPR2, Contactin-2), AMPAR, GABA(B)R, NMDAR, Glycine R, Dopamine-2 R
Antibodies against intracellular antigens
• Onconeural antibodies; Hu, Yo, Ri, CV2, amphipysin, Ma2, GAD
Graus at al., 2010 J Neurol. 257(4); 509-17
Vincent et al., 2011 Lancet Neurol. 10(8):759-72
Pathogenic role autoantibodies
Presence of autoantibody
Autoantigen/antibody as part of the disease
IgGs/autoantibodies can target CNS
IgGs are at target sites in CNS
Serum CSF
3.125
6.25
12.5
25
50
100
200
400
800
1600
3200
6400
3.125
6.25
12.5
25
50
100
200
400
800
1600
3200
6400
Dilu
tio
n o
f se
rum
Dilu
tion
of C
SF
Mechanisms of antibody-induced
pathology
Direct block
Internalisation
Complement-
dependent lysis
Cell-based assays
Antigen
Patient has antibodies
Binding can be scored visually or titrations
performed
Clinical syndromes in CNS autoimmunity
• Limbic encephalitis • Seizures
• FBDS • PERM • Catastrophic/severe seizures
• Movement disorder • Encephalitis lethargica
• Neuropsychiatric • Others
• Cross over with peripheral syndromes • Demyelination
Case 1 15yr F
• GTCS • 1/52 feeling unwell/rundown. Known to social services for
violent episodes and regular cannabis use. • Generalised +Rt Focal seizures. I+V for seizure control. • Hallucination (auditory and visual), complaining of extreme
pruritis, violent outbursts, delirious state. • EEG slow wave Rt>Lt. Sharp wave Rt fronto-temporal
parietal. • MRI hyperintensity involving both hippocampi and
amygdala, swelling of mesial temporal structures. High dose steroids, IVIG good response
Case 1
Sub-acute onset of memory loss, seizures and personality change
Sometimes seizures or psychosis only
Often low plasma sodium
VGKC-complex antibodies often
very high titre
<10% tumours
Most respond well to immunotherapies
A treatable form of limbic encephalitis
Buckley et al., 2011 Ann Neurol. Jul;50(1):73-8.
Vincent et al., 2004 Brain 127; 701-12
Antibodies against the VGKC- complex
• At least three accessory proteins; CASPR2, LGI1 and Contactin-2 • CASPR2 found in patients with Morvan’s syndrome or neuromyotonia,
– Many of whom have a thymoma
• LGI1 found in patients with medial temporal lobe seizures associated with limbic encephalitis
– Non paraneoplastic
Irani et al., 2010 Brain 133(9):2734-48
AD
AM
22
/23
O
the
r
?
LG
I1
Kv1
s
CA
SP
R2
Co
nta
cti
n-2
Lai et al., 2010 Lancet Neurol 9: 776-85
Other forms of limbic encephalitis
• Glutamic acid decarboxylase Malter et al., 2010 Ann Neurol 67; 470-478
• Younger and often only had seizures without the
other limbic feature
• None had tumours
• CSF active (OLB Positive)
• More chronic disease
• Thyroid antibodies – Hacohen et al., 2013 J Child Neurol Mar 20 Epub
– Haberlandt et al., 2011 Arch Dis Child 96(2):186-91
Case from Irani et al., 2011 Ann Neurol 69(5): 892-900
Faciobrachial Dystonic Seizures (FBDS)
• Seen in limbic encephalitis with VGKC-complex-Abs (mostly LGI1)
• Can precede neuropsychiatric and MRI features of limbic encephalitis
• Often poor response to AEDs and adverse reactions
• Good and surprisingly fast response to prednisolone
Irani et al., 2011 Ann Neurol 69(5): 892-900
54-year old prison officer presenting with whole-body jerks triggered
by auditory and tactile stimuli
Video from Hutchinson et al., 2008 Neurology 71(16):1291-2
Hutchinson et al., 2008 Neurology 71(16):1291-2
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody
VGKC antibodies in paediatric encephalitis presenting with status epilepticus
• 10 patients with unexplained encephalitis presenting with status epilepticus and refractory seizures
• 4 patients positive for VGKC antibodies. • These antibodies are not directed against LGI1 and Caspr2.
• No other antibodies were detected.
Suleiman et al., 2011 Neurology 76 ; 1252-5
Febrile infection-related epilepsy
syndrome (FIRES) Baalen et al., 2010 Epilepsia 51(7); 1323-1328
• Idiopathic catastrophic Baxter et al., 2003 Seizure 12; 379-87
• Devastating epileptic encephalopathy in school age children (DESC) Mikaeloff et al., 2006 Epilepsy Res 69; 67-69
• Acute encephalitis with refractory, repetitive partial seizures (AERRPS) Sakuma et al., 2010 Acta Neurol Scand 121(4); 251-6
• New Onset Refractory Status Epilepticus Costello et al., 2009 J Neurol Sci. 15;277(1-2); 26-31
Previously well
Febrile prodrome followed by encephalopathy and fulminant seizures
Refractory seizures (not invariable)
Acute encephalopathy with inflammation-mediated status epilepticus
Nabbout et al., 2011 Lancet Neurol. 10(1); 99-108
Nabbout 2012 Epilepsia 2012 53 Suppl 4; 58-62
Case 2
• 22 months
• Seizures
• Agitation
• Relentless choreo athetoid movements
• Bulbar dysfunction
• Autonomic instability
Agrawal et al., 2010 ADC 95(4); 312
Case 2
Presentation 4 months
Courtesy or family and Dr E Wassmer, BCH
NMDAR antibody encephalitis
• Antibodies to the N-methyl-D-aspartate subtype of glutamate receptors
• Both paraneoplastic and non-paraneoplastic forms
• Young women with ovarian teratomas
• Presentation with seizures, cognitive problems or psychiatric features
Dalmau et al., 2007 Ann Neurol 61(1); 25-36
Titulaer et al., 2013 Lancet Neurol.12(2):157-65
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer et al., 2013 Lancet Neurol 12(2):157-65
Titulaer et al., 2013 Lancet Neurol. 12(2):157-65
Titulaer et al., 2013 Lancet Neurol. 12(2):157-65
Titulaer et al., 2013 Lancet Neurol 12(2):157-65
Esseveld et al., 2012 Am J Psychiatry 170 21-2
Finke et al., 2013 Ann Neurol April 26 Epub
Case 2 -1 year later
Spectrum of NMDAR antibody mediated disease
• Dyskinetic form of encephalitis lethargica Dale et al., 2009 Ann Neurol 66:704-709
• Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child
Goldberg et al., 2011 Neuropediatrics;42(5):188-90.
• Isolated hemidystonia associated with NMDA receptor antibodies
Rubio-Agustí et al 2011 Mov Disord 1;26(2):351-2.
• Disease-relevant autoantibodies in first episode schizophrenia Zandi MS et al., 2011 J Neurol 258(4):686-8.
NMDAR antibody mediated movement disorder
Presentation 6 weeks later
NMDAR antibody mediated movement disorder?
Dale et al., 2012 J Child Neurol. 27(11):1470-81
Autoimmune basal ganglia disorders
D2R antibodies in basal ganglia encephalitis
• 12/17 children (age 0.4-15yrs) • Movement disorders, parkinsonism, dystonia
and chorea. • Psychiatric disturbance with emotional lability,
attention deficit and psychosis • Elevated IgG to extracellular D2R • No binding to D1,3,5 and DAT. • D2R Abs in 10/30 SC, 4/44 TS, 0/22 PANDAS
Dale et al., 2012 Brain 135(Pt 11):3453-68
Infection and auto-immunity in schizophrenia
Increased risk of autoimmunity in patients
Benros et al., 2012 Ann N Y Acad Sci. 1262:56-66
Increased risk of infection
HLA associations in schizophrenia
• Common disease, common variant model.
• A region of association of common SNPs with schizophrenia was identified at the MHC region.
• Pathway analysis of GWAS: pathways consistently found relate to metabolism of glutamate, the process of apoptosis, inflammation, and immune system.
Stefansson et al., 2009 Nature 460(7256): 744–747
Jia et al., 2010 Schizophr Res. 122(1-3):38-42
Innate system upregulation in schizophrenia
• Activated microglia in post-mortem studies.
• Increased blood brain-barrier permeability.
• Elevated levels of IL6 and altered IL2/IFN-g system regulation.
Strous & Schoenfeld 2006 J Autoimmun. 27(2):71-80.
Autoimmunity and neuropsychiatric disorders
Presence of autoantibodies against brain, brain structures and receptors
Jones et al., 2005 Immunol Cell Biol. 83(1):9-17 Tanaka et al., 2003 Neuroimmunol. 141(1-2):155-64.
Autoimmunity and neuropsychiatric disorders
• Patients present prominent psychiatric alterations, among other neurological manifestations, usually responsive to immunotherapy
• Autoantibodies against synaptic receptors and trans-synaptic proteins are found
Kayser & Dalmau 2011 J Neuropsychiatry Clin Neurosci 23(1):90-7
Autoimmunity in neuropsychiatric disorders
• Zandi et al., 2011 J Neurol. 258(4):686-8 Almost 9% (4/46) had autoantibodies (NMDAR and VGKC), exhibiting no differentiating clinical features from other psychotic patients
• Kayser et al., JAMA Neurology 2013 July 22 Epub 23/572 NMDAR positive patients had isolated neuropsychiatric syndrome but only 5 were first presentation
• Hammer et al., 2013 Molecular Psychiatry Sept 3 Eub 10% subjects (2817) had NMDAR antibodies
• Rarely occur in isolation Part of a wider encephalopathy
Symptoms can predate for a while
• Primary or secondary
• Paraneoplastic on adults and less so in kids
• Aetiological or still causing a problem?
• Start treatment before results
Need to treat early and long for best outcome
Immune neuropsychiatric disorders
Hacohen et al. 2013 J Neurol Neurosurg Psychiatry 84 (7); 748-55
When to suspect? Modified from Zuliani et al., 2012 J Neurol Neurosurg Psychiatry 83(6):638-45
• Acute or subacute (<12 weeks) onset » Recognisable syndrome
» Viral or fever prodrome
» Previously normal
• Evidence of CNS inflammation (at least one of) » CSF, MRI or inflammatory neuropathology
• Exclusion of infective and life-threatening metabolic causes
Lim 2012 SETPEG, ECH
Professor Angela Vincent.
Dr Bethan Lang
Dr Patrick Waters
Drs C Buckley & M Leite
Dr Yael Hacohen
Dr Sukhvir Wright
Drs M Woodhall & L Jacobs
Children’s Neurosciences
Do antibodies alter neuronal excitability?
VGKC/LGI1 Ab IgG elicits epileptiform activity in the CA3 area of hippocampus in brain slices
Extracellular potentials recorded in the stratum lucidum of CA3 pyramidal cell layer with extracellular stimulation of mossy fibres
Lalic et al., 2011 Epilepsia 52(1):121-31
VGKC/Lgi1 IgG increases burst activity in CA3 Reduces no of failures to stimulation Effects similar to dendrotoxin
Mikasova et al., 2012 Brain 135; 1606–1621
Patient CSF reduces dendritic density of GluN2B and GluN2A
Prevents LTP of glutamate synapses
Hughes et al., 2010 J Neurosci. 28;30(17):5866-75
Antibodies internalise NMDARs in hippocampal neurons
and reduce NMDARs after injection into mice
NMDAR antibodies associated with minimal T cells
VGKC-complex antibodies associated with CD8 T cell
infiltrates and perforin release
Bien et al., 2012 Brain135(Pt 5):1622-38.
VGKC-complex antibodies associated with neuronal
loss and APP deposits.
NMDAR antibodies associated with no neuronal loss or deposits
Bien et al., 2012 Brain135(Pt 5):1622-38.
Tumours contain neuronal cells
and express NMDAR
Tuzun et al., 2009 Acta Neuropathol 118(6):737-43
Working out the biology of receptors
Paoletti et al., 2013 Nat Rev Neurosci 14(6):383-400
Paoletti et al., 2013 Nat Rev Neurosci 14(6):383-400
The role of immunotherapy maybe beyond immune suppression
Zito and Scheuss 2009
Antibodies in epilepsy
235 follow-up and 181 new
onset epilepsy patients
screened plus 148 controls
11%* of patients had
antibodies to one or more
antigen
Brenner et al., 2013 Epilepsia Mar 6. doi: 10.1111/epi.12127
Positive Negative Total
Epilepsy (no. of patients)
35* 255 290
Controls (no. of patients)
11 169 180
Total 46 424 470
8
13 3 1 3
7
NMDA
VGKC
VGKC+NMDA
GLYCINE
CONTACTIN-2
CASPR2
Paediatric epilepsy cohorts
Dutch and Australian cohort of children with first onset seizures
Suleiman & Wright et al., (submitted)
2
VGKC in adults with seizures
Serum antibodies in epilepsy and seizure-associated disorders. McKnight, K; BM, MRCP; Jiang, Y; Hart, Y; MD, FRCP; Cavey, A; Wroe, S; MD, FRCP; Blank, M; Shoenfeld, Y; MD, FRCP; Vincent, A; Palace, J; Lang, B Neurology. 65(11):1730-1736, December 13, 2005. DOI: 10.1212/01.wnl.0000187129.66353.13
Figure 1 Antibodies to voltage-gated potassium channels (VGKCs) in the sera of patients with seizures and controls. Antibodies were measured by immunoprecipitation of [125I]-[alpha]-dendrotoxin-labeled VGKCs and are expressed in pM. Antibody titers were considered positive if greater than 100 pM (mean titer + 3 SD above the mean of the healthy controls). IC = immune cohort; DRC = drug-resistant cohort; REG = referred epilepsy group; MS = multiple sclerosis; OND = other neurologic disease; HCon = healthy controls; Pos = positive-titer serum from patients with neuromyotonia, known to have high VGKC antibody titers.